Shah Preetam Insider Trades

Insider Trading History

Track insider trading activity for Shah Preetam. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Elicio Therapeutics
Elicio Therapeutics ELTX
See Remarks
Holding Value $667k 47,900 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$582k 71,900 shares
$8.10
$13.93
Elicio Therapeutics
Elicio Therapeutics ELTX
See Remarks
Holding Value $2.67M 191,624 shares
Last Trade
Apr 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$954k 191,624 shares
$4.98
$13.93
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Financial Officer
Holding Value $28.8M 130,087 shares
Last Trade
Sep 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 130,087 shares
$10.75
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CFO & CBO
Holding Value $74.4M 335,960 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.98M 217,500 shares
$13.70
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CFO & CBO
Holding Value $50.3M 227,210 shares
Last Trade
Mar 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$250k 18,931 shares
$13.22
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CFO & CBO
Holding Value $52.7M 238,141 shares
Last Trade
Mar 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.64M 180,000 shares
$20.20
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CFO & CBO
Holding Value $32.8M 148,141 shares
Last Trade
Mar 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$230k 6,648 shares
$34.60
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CFO & CBO
Holding Value $33.4M 150,789 shares
Last Trade
Sep 19, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$238k 15,642 shares
$15.20
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CFO & CBO
Holding Value $0 0 shares
Last Trade
Sep 15, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$722k 50,000 shares
$14.43
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CFO & CBO
Holding Value $36.8M 166,431 shares
Last Trade
Sep 15, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$722k 50,000 shares
$14.43
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CFO & CBO
Holding Value $24.9M 112,431 shares
Last Trade
Mar 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$413k 24,820 shares
$16.65
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CFO & CBO
Holding Value $30.4M 137,251 shares
Last Trade
Mar 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.1M 66,001 shares
$16.65
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CFO & CBO
Holding Value $4.43M 20,000 shares
Last Trade
Nov 12, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$644k 20,000 shares
$32.20
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CFO & CBO
Holding Value $69M 311,850 shares
Last Trade
Sep 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.8M 311,850 shares
$44.40
$221.38
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Evp, CFO And Treasurer
Holding Value $9.82k 11,600 shares
Last Trade
Dec 30, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.74M 25,000 shares
$69.45
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Evp, CFO And Treasurer
Holding Value $31k 36,600 shares
Last Trade
Dec 24, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$687k 11,600 shares
$59.25
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Evp, CFO And Treasurer
Holding Value $84.7k 100,000 shares
Last Trade
Sep 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.06M 100,000 shares
$60.60
$0.85

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up